 Provider News VirginiaNovember 2024 Provider Newsletter Contents Quality Management | Anthem Blue Cross and Blue Shield | Commercial / Anthem Blue Cross and Blue Shield | Medicare Advantage / HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 25, 2024 Time to prepare for HEDIS medical record reviewQuality Management | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 24, 2024 Provider: CAHPS awareness
VABCBS-CDCRCM-070468-24 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). The Department of Health & Human Services (HHS) requires health plans to report whether or not our in-network providers offer telehealth services. If you provide telehealth services, please tell us by submitting your information to us through Availity.com. Updating your telehealth status will not affect your participation with us. We will add a telehealth indicator to your online provider directory profile, allowing our members to know you offer telehealth services. If you have questions about submitting your information, please see the instructions below. If your organization is not currently registered with Availity, you will need to create an account. The person(s) designated as your administrator(s) should go to Availity.com and select Get Started in the upper right corner of the webpage. You may also navigate directly to Availity’s registration website by selecting here. Begin your application here. To update your application: - Log in to Availity Essentials.
- Select My Providers.
- Select Provider Data Management.
Please update your telehealth information at the service location. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069888-24-CPN69222 Administrative | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | November 1, 2024 New claims edits system enhances drug safetyBeginning with claims processing on or after February 1, 2025, (90-day MAC notice required) HealthKeepers, Inc. is enhancing its claims edits system to ensure claims billed with pharmaceutical drug procedure codes are reported with an FDA-approved indication or an approved off-label indication on the claim. These enhanced claim edits provide an opportunity for HealthKeepers, Inc. to evaluate submitted claims for drug quality, safety, and effectiveness. The enhancement is to have the claims deny if the diagnosis reported is not one that is an FDA-approved indication or an approved off-label indication for the drug procedure code. If you believe a claim reimbursement decision should be reviewed, please follow the normal claims dispute process outlined in the provider manual and include medical records that clarify whether the indication was approved through the governing agencies. You will only need to submit the portion(s) of the medical record that is relevant to the drug provided. If you have any questions about this communication, contact Anthem HealthKeepers Plus Provider Services at 800-901-0020. HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-068202-24 This article was updated as of November 1, 2024. Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. will notify you by mail of an upcoming provider contract amendment, which includes a statewide fee schedule update, on November 26, 2024. On that date, log on to Availity Essentials to select the Provider Online Reporting application to securely access and download a digital copy of the amendment documents. Only authorized users in your practice or facility can view the confidential contract amendments using Provider Online Reporting. Authorization must be obtained through your Availity administrator if you do not currently have access. For easy reference, below is the information needed for getting started with Provider Contract and Fee Schedule Notifications. Provider online reporting reference guide: how to get startedProvider Online Reporting is found on Availity.com. This is where you can access the updated fee schedule. Below is a recap of the application and instructions on how to sign up and access notifications. We suggest Google Chrome as your internet browser. For Availity administrators: how to assign accessIf your organization is not currently registered with Availity Essentials, go to Availity.com and select Register to complete the online application. As an administrator, you must take the following steps to assign access to Provider Online Reporting: - Assign the user role of Provider Online Reporting to your Availity Essentials access.
- Select Payer Spaces in the top menu bar and choose the payer tile that corresponds to the market.
- First-time users accessing Payer Spaces will be asked to accept a Terms of Use Agreement. The agreement will appear for users once every year.
- On the Applications tab, select Provider Online Reporting.
- Select Organization and then select Submit.
- On the Welcome to Provider Online Reporting page, select Register/Maintain Organization.
- Select Register Tax ID(s) for the applicable program to register the tax IDs.
- A pop-up window will display all tax IDs that must be registered for the program. Mark the box for each tax ID to be registered and select Save.
- Tax ID registration has now been successfully completed. Notice that after the registration has been completed, the status has changed from Register Tax ID(s) to Edit Tax ID(s).
For users: how to navigate to the reportTake the following steps to navigate to the report: - Log in to Availity.com.
- Select Payer Spaces in the top menu bar.
- Select the payer tile that corresponds to your market.
- Accept the Terms of Use Agreement (once every year).
- On the Applications tab, select Provider Online Reporting.
- Select Organization and then select Submit.
- Select Report Search. Choose the type of report, then launch your program’s reporting application.
The Welcome to Provider Online Reporting webpage will open. This page lists all the organization’s eligible programs. Use the navigation options on the left-hand side of the page to move within the tool. The Programs page provides a description about the program in which your organization participates and includes any applicable documents related to your program. Select a program using the dropdown menu. The Report Search page launches the corresponding reporting application for your program. Select the appropriate program from the dropdown menu. Helpful tipAdd Provider Online Reporting to My Favorites for quick access on Availity.com: - Log on to Availity.com.
- Select Payer Spaces in the top menu bar.
- Select the payer tile that corresponds to your market.
- On the Applications tab, select the heart icon next to Provider Online Reporting. The heart will turn red.
- Provider Online Reporting will now appear at the top under My Favorites.
For assistance:Visit the Custom Learning Center in Payer Spaces to view Provider Online Reporting user guides. - If you have questions regarding Availity Essentials, contact Availity Client Services at
800-282-4548. - If you have questions about Provider Online Reporting, use the Contact Us section on the application.
- If you have other questions, reference the number on the back of the member ID card for Provider Services.
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CM-060738-24, VABCBS-CDCM-070587-24 In July, we announced an enhancement to the 277CA to notify you of submission errors discovered during claims processing.
As of November 1, 2024, the 277CA will include additional corrective action types for your review. As communicated in July, these errors will still be sent through physical mailing.
With these added error types, there is no reduction to the services we already provide.
Through our efforts, we are committed to reducing administrative burden, improving communication, and ensuring timely payments because we value you, our care provider partners.
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069544-24-CPN69313 Find Care, the doctor finder and transparency tool in the Anthem online directory, provides Anthem members with the ability to search for in-network providers using the secure member website. This tool currently offers multiple sorting options such as sorting providers based on distance, alphabetical order, and provider name. In our November 2022 newsletter, we provided an update regarding Personalized Match, an additional Find Care sorting option for Commercial members. We informed you that this provider sorting option was based on provider efficiency and quality outcomes described in a methodology document linked in the newsletter article, in addition to member search radius. We want to inform you that, beginning in December 2024 or later, we will be enhancing Personalized Match. This will expand upon the existing program. Newer components of the provider personalization metrics will contain up to 10 times as many features as compared to existing metrics such as gaps in care and additional types of service cost and utilization. Personalized Match will continue to display providers with the highest overall ranking within the member’s search radius, first. Members will continue to have the ability to sort based on distance, alphabetical order, and provider name. Helpful resources on AvailityYou may review a copy of the Personalized Match methodology that has been posted on Availity, our secure web-based provider tool, using the following navigation: - Go to Availity > Payer Spaces > Health Plan > Education & Reference Center > Administrative Support > Personalized Match Methodology.pdf.
If you have general questions regarding these upcoming changes, please submit an inquiry via the web at Availity.com. If you would like information about your quality or efficiency scoring used as part of this sorting option or if you would like to request reconsideration of those scores, you may do so by submitting an inquiry to Availity.com. Anthem will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-061391-24, MULTI-BCBS-CM-070287-24 Digital Solutions | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | November 1, 2024 Enhanced personalized match: making the care provider search more informed and personalizedSummary: - The Personalized Match sorting option in the Find Care tool will be enhanced to provide more personalized care provider suggestions based on gaps in care and member history derived from clinical data, beginning December 2024.
- Members will be able to find details on the enhanced Personalized Match methodology in the online directory, and care providers will be able to submit inquiries or request reconsideration of care provider scores.
Find Care, the provider finder and transparency tool in the Anthem online directory, allows members to search for in-network care providers using the secure member website at anthem.com/find-care. This tool currently offers multiple sorting options, such as sorting providers based on Personalized Match, distance, alphabetic order, and care provider name. Beginning December 2024 or later, the Personalized Match sorting option will be enhanced for members. This sorting option currently considers care provider efficiency and quality outcomes. Enhancements will include gaps in care, such as HEDIS® measures and other market-specific clinical care measures, knowledge about member history derived from claims and other available clinical data, and member search radius. Care provider pairings with the highest overall ranking within the member’s search radius will be displayed first. Members will continue to be able to sort based on distance, alphabetic order, and care provider name: - You may review a copy of the Personalized Match methodology that has been posted on Availity Essentials — our secure web-based care provider tool — using the following navigation: Go to Availity.com > Payer Spaces > Select the Payer > Provider Online Reporting > Programs > Select a Program > Personalized Match > Personalized Match Methodology Phase 2 - Medicaid.pdf.
- If you have general questions regarding this new sorting option, please submit an inquiry to Availity.com.
- If you would like information about your quality or efficiency scoring used as part of this sorting option or if you would like to request reconsideration of those scores, you may do so by submitting an inquiry to Availity.com.
Going forward, we will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-065656-24-CPN65561 Anthem has a continued mission to leverage digital technology to provide enhanced services for both members and care providers. We encourage the support of care providers in accepting digital ID cards instead of a physical member ID card. As members increasingly use digital ID cards, care providers may need to implement changes in their processes to accept this format. Due to recent enhancements, care providers can bypass the request for cards by accessing Availity.com. If a copy of a physical member identification card is needed, a member can email, fax, or access card details saved in their digital wallet. As a reminder, care providers can also access eligibility and benefit information without the health care identification (HCID). This makes both check-ins and submitting claims easier and faster. Anthem is dedicated to providing digital solutions that transform both care provider and payer interactions. Thank you in advance for your continued partnership and support in empowering our members to use their digital ID cards. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069066-24, MULTI-BCBS-CM-077976-25 We are excited to announce the release of an Applied Behavior Analysis (ABA) Provider Resource Guide designed to assist with proper billing and documentation practices. This essential guide simplifies the complexities of ABA coding and requirements, ensuring that you can navigate these processes with ease. Refer to attached ABA Provider Resource Guide. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-072382-24-CPN72379 ATTACHMENTS (available on web): ABA Provider Resource Guide - Anthem Blue Cross Blue Shield (pdf - 0.39mb) Behavioral Health | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | November 1, 2024 LAI injectable antipsychotics can improve clinical outcomes in serious mental illness populationSummary: - Long-acting injectable (LAI) antipsychotics enhance adherence, reduce relapses, and improve outcomes in schizophrenia.
- They are recommended for chronic nonadherence, first-episode psychosis, and early-stage schizophrenia patients.
- They stabilize drug levels, reduce daily medication stigma, and allow better monitoring by healthcare providers.
The American Psychiatric Association’s practice guideline for treatment of patients with schizophrenia recommends the use of LAI antipsychotics in patients who prefer long-acting injectables or have a history of poor or uncertain adherence.4 LAI antipsychotics are commonly used in patients with chronic nonadherence or multiple relapses; however, experts suggest that patients with first-episode psychosis or early-stage schizophrenia may benefit most.1,2 Early use of LAI antipsychotics may help increase treatment response, prevent relapse, and reduce structural neurologic changes in early disease. Patients at high risk for poor adherence or relapse should also be considered for LAI antipsychotics. When used in combination with cognitive and behavioral techniques that help patients understand their illness and need for treatment, LAI antipsychotics may help some patients break a cycle of multiple hospitalizations resulting from unstable illness. Clinical benefits of LAI use include: - Improved medication adherence: The biggest advantage of long-acting injectable antipsychotics is that they significantly improve medication adherence because they largely eliminate the need for daily pill taking.
- Stable drug levels: Long-acting injectables provide steady and controlled release of the medication, helping maintain consistent blood levels of the drug and may lead to better therapeutic consistency and fewer side effects.
- Monitoring: The use of long-acting injectables allows healthcare providers to better monitor treatment adherence, which can be vital in managing conditions like schizophrenia or bipolar disorder.
- Fewer relapses: Several studies have shown that using LAI antipsychotics can help patients avoid psychiatric hospitalizations and reduce the frequency of relapses.
- Less daily impact: A regular injection may be less disruptive or stigmatizing than taking daily oral medications, particularly if the injections can be administered at a general healthcare provider, rather than a psychiatric facility.
- No first-pass metabolism: Unlike oral medications, LAI antipsychotics bypass the gastrointestinal tract and first-pass metabolism in the liver so they can often be given in lower doses with similar therapeutic efficacy.
Typically, patients are transitioned to the LAI formulation of the same oral antipsychotic they responded to. However, it is important to consider other factors in the selection such as patient comorbidities and potential side effects. Like oral medications, second-generation LAI antipsychotics are favored because of their more favorable side effect profile. See this table adapted from Guide to Long-Acting Medications. LAI best practices:- Focus on member preference for treatment, empowering the member to take ownership and understanding of their treatment plan.
- During administration use the proper injection technique and systematically rotate the injection site.
- Discuss potential side effects and educate members on what to do in an emergency, such as if they are having suicidal thoughts.
- Ensure maintained appointment availability in practice for patients and schedule follow-up appointments and subsequent injections before the patient leaves the current appointment.
- Outreach patients who cancel appointments and reschedule as soon as possible to maintain medication adherence and continuity of care.
- Obtain baseline diabetes initial screening, test again three to four months later, then order annually.
- Order a yearly diabetes screening test for all patients on antipsychotic medication.
- Include a family member or caregiver in discussions regarding treatment when able.
Quality impact — Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA) HEDIS® measure:- SAA measure description: the percentage of members 18 years of age and older during the measurement year with schizophrenia or schizoaffective disorder who were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period.
- Inclusion criteria:
- Members with either one acute inpatient encounter or two outpatient encounters with a diagnosis of either schizophrenia or schizoaffective disorder with at least two antipsychotic medication dispensing events
- Members aged 18 and older covered under Commercial, Medicaid, or Medicare lines of business
- Exclusion criteria:
- Members with dementia
- Members over the age of 80 diagnosed with frailty
- Members using hospice services at any time during the year
- A member passes the measure when their proportion of days covered (PDC) for their antipsychotic medications is at least 80% of their treatment period.
References:
- Brasso C, Bellino S, Bozzatello P, Montemagni C, Nobili MGA, Sgro R, Rocca P. Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient's Subjective Quality of Life, Well-Being, and Satisfaction. J Clin Med. 2023 Nov 8;12(22):6
- Lin D, Thompson-Leduc P, Ghelerter I, Nguyen H, Lafeuille MH, Benson C, Mavros P, Lefebvre P. Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States
- ncqa.org/hedis/measures
- Keepers, George A., et al. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. American Journal of Psychiatry, https://psychiatryonline.org/doi/full/10.1176/appi.ajp.2020.177901, vol. 177, no. 9, American Psychiatric Publishing, Sept. 2020, pp. 868–872, doi:10.1176/appi.ajp.2020.177901. September 01, 2020
- ncqa.org/hedis/measures/adherence-to-antipsychotic-medications-for-individuals-with-schizophrenia/
HEDIS ® is a registered trademark of the National Committee for Quality Assurance (NCQA). HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-069181-24-CPN69039 The Affordable Care Act (ACA) requires many health plans to cover recommended preventive care services without member cost sharing when the services are rendered by an in-network provider and/or facility. Screening colonoscopies (even when polyps are removed) are included as a covered preventive care service. Since colonoscopies are rendered for both screening and diagnostic purposes, it is important for providers to use appropriate coding guidelines when reporting colonoscopies. When inappropriate CPT® and ICD-10-CM codes are submitted on claims, it can result in incorrect provider payment and/or incorrect member cost sharing. The following services are covered with no member cost share: - The colonoscopy screening procedure
- Anesthesia charges when anesthesia is billed with the appropriate screening CPT code (even when polyps are removed)
- Other associated facility charges when the colonoscopy is billed with an appropriate screening diagnosis code
- When polyps are removed during a screening colonoscopy — the removal, examination, and analysis of the polyps
When a screening colonoscopy starts out as screening but turns into a diagnostic procedure due to polyps being removed, Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. follow CPT guidelines for the Commercial benefit plans — not Medicare guidelines. The CPT 2018 Professional Edition manual shares the following information regarding the billing of anesthesia for any screening colonoscopy: “Report 00812 to describe anesthesia for any screening colonoscopy regardless of ultimate findings.” We are committed to helping our members more easily access the care they need. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CM-071520-24 Education & Training | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 23, 2024 Updated place of service code requirements for telehealth billingTo align with Department of Medical Assistance Services requirements, we are updating our claims processing system. All telehealth claims billed with a date of service on or after November 1, 2024, must use place of service codes (POS) 02 or 10 only.
This update will retroactively allow POS code 02 back to May 13, 2024. Claims using POS 02 may continue to be denied until November 1, 2024, but will be reprocessed after this update is complete.
State guidance on telehealth services can be found here.
Place of service code(s)
|
Place of service name
|
02
|
Telehealth Provided Other than in Patient’s Home
|
10
|
Telehealth Provided in Patient’s Home
|
If you have any questions about this communication, call Anthem HealthKeepers Plus Provider Services at 800-901-0020. HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-068176-24 Education & Training | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 23, 2024 Reminder: take action to protect infants from respiratory syncytial virus this seasonAs respiratory syncytial virus (RSV) season approaches, we would like to remind providers about available RSV immunizations to help prevent severe RSV related disease in infants. According to a report from the CDC (March 2024), infant preventive antibodies showed 90% effectiveness against the need for hospitalization for RSV in babies. Two immunizations are available to prevent RSV lower respiratory tract infections in infants: - Pfizer's Abrysvo, a maternal vaccine given during pregnancy
- Nirsevimab (Beyfortus), a monoclonal antibody administered to the baby
The maternal vaccine, Abrysvo, is recommended for those who are 32 to 36 weeks pregnant during RSV season, which generally falls between October and March. The vaccine can provide protection for infants up to six months if the mother receives it at least two weeks prior to delivery. Nirsevimab (Beyfortus) provides up to five months of protection against RSV and is approved for infants under 8 months during their first RSV season, and certain children between 8 and 19 months at increased risk of severe RSV disease. In some cases where a mother received an RSV vaccine, Nirsevimab can still be considered for the child if there is a substantial risk for severe RSV disease or if the maternal immune response to the vaccination is inadequate. Nirsevimab is covered under the Vaccines for Children Program. Additional information about RSV prevention and Nirsevimab (Beyfortus) can be found at cdc.gov/rsv. We look forward to sharing resources and working with you to achieve improved outcomes for children in our communities. HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-068155-24-CPN67753 Education & Training | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 16, 2024 Virginia healthcare providers: enhance your skill set in healthcare for people with intellectual and developmental disabilitiesPlease open this flier to learn more about opportunities to enhance your skill set in caring for patients with intellectual and developmental disabilities. Upon completion of this course, you will earn CME credits. HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-069737-24 As a contracted provider for a special needs plan (SNP) from Anthem, you are required to participate in an annual Model of Care training for providers, per CMS regulations. This training includes a detailed overview of Anthem special needs plans and program information, highlighting cost sharing, data sharing, participation in the Interdisciplinary Care team (ICT), where to access the member’s health risk assessment results, plan of care, and benefit coordination. Please remember this training is specific to our plans and delivery of care for members, ensuring their specific care needs are met. Your participation is critical for improved quality and health outcomes. Training for the SNP product is self-paced and available at Availity.com. The training must be completed by December 31, 2024. How to access the Custom Learning Center:- Log in to the Availity website at Availity.com.
- At the top of the Availity website, select Payer Spaces and select the appropriate payer.
- On the Payer Spaces landing page, select Access Your Custom Learning Center from Applications.
- In the Custom Learning Center, select Required Training.
- Select Special Needs Plan and Model of Care Overview.
- Select Enroll.
- Select Start.
- Once the course is completed, select Begin Attestation and complete.
Not registered for Availity Essentials?Have your organization’s designated administrator register your organization for the Availity website: - Visit Availity.com to register.
- Select Register.
- Select your organization type.
- In the Registration wizard, follow the prompts to complete the registration for your organization.
Refer to these PDF documents for complete registration instructions. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-070560-24-CPN70218 In the July 2024 edition of Provider News, we announced the transition to the following Carelon Medical Benefits Management guidelines: Site of Care for Advanced Imaging, Rehabilitative Site of Care, and Surgical Site of Care, effective September 1, 2024. To clarify, existing prior authorization requirements have not changed, and this does not equate to the presence of a site of care review requirement. In the event a site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such requirements. You may access and download a copy of the current and upcoming guidelines here. Site of Care Guidelines: - Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
Please share this notice with other members of your practice and office staff. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-067576-24-CPN67268 Guideline Updates | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 2, 2024 Clarification to Carelon Medical Benefits Management, Inc. updates effective September 1, 2024In the July 2024 edition of Provider News, we announced the transition to the following Carelon Medical Benefits Management guidelines: Site of Care for Advanced Imaging, Rehabilitative Site of Care, and Surgical Site of Care effective September 1, 2024. To clarify, existing prior authorization requirements have not changed, and this does not equate to the presence of a site of care review requirement. In the event a site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such requirements. You may access and download a copy of the current and upcoming guidelines here: - Site of Care Guidelines:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
Please share this notice with other members of your practice and office staff. HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-067602-24-CPN67275 Effective November 17, 2024 This article was updated on November 24, 2024 to change the effective date from October 26, 2024 to November 17, 2024. Effective on November 17, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guideline updates will be adopted for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management, Inc. guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement. You may access and download a copy of the current and upcoming guidelines here: - Musculoskeletal:
- Site of Care:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
The above guideline updates have a publish date of November 17, 2024. Please share this notice with other members of your practice and office staff. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-065139-24-CPN64434, MULTI-ALL-CR-074348-24 Guideline Updates | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | September 30, 2024 Carelon Medical Benefits Management, Inc. updatesEffective November 30, 2024 Effective on November 30, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines updates will be adopted for HealthKeepers, Inc. This article is to communicate the plan adoption of these Clinical Appropriateness Guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement. You may access and download a copy of the current and upcoming guidelines here. - Genetic Testing:
- Cell-free DNA Testing for the Management of Cancer
- Prenatal Testing using cell-free DNA
- Somatic Tumor Testing
- Musculoskeletal:
- Joint Surgery
- Small Joint Surgery
- Site of Care:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
The above guideline updates have a publish date of November 17, 2024. Please share this notice with other members of your practice and office staff. HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-067238-24-CPN66675 Coverage and Clinical Guidelines | Anthem Blue Cross and Blue Shield | Commercial / Anthem Blue Cross and Blue Shield | Medicare Advantage / HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | November 1, 2024 Expand access to specialty care with virtual consults — now available in VirginiaWe are partnering with AristaMD to offer providers virtual support in clinical decision making.
As we continue to look for unique ways to support care providers, we have partnered with AristaMD to allow providers to virtually connect with specialists for clinical decision support at no cost.
AristaMD offers a specialist network and platform, built by physicians for physicians, for transmitting and billing eConsults. A turn-key solution offering access to over 70 specialties, AristaMD has a proven track record of helping PCPs optimize care plans and provide rapid access to specialists. To learn more about eConsults and AristaMD, visit their website at aristamd.com.
We cover the cost of using AristaMD to conduct eConsults for Virginia patients enrolled in our Medicaid, Medicare Advantage, or Commercial health plans. AristaMD is an independent company providing services for our network providers and their patients along with other health plans.
We are committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities.
To learn more about eConsult options, contact your Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. representative or email our team directly at virtualconsults@elevancehealth.com. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CDCRCM-067632-24 Coverage and Clinical Guidelines | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | September 24, 2024 Medical Policies and Clinical Utilization Management Guidelines updateEffective October 26, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit Recent Provider Medical Policy Full list | Anthem.com. Notes/updatesUpdates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive: - MED.00055 — Wearable Cardioverter Defibrillators:
- Reformatted language from the to a wearable cardioverter defibrillator and moved punctuation
- Added Not Medically Necessary statement when individual has an automated external defibrillator
- MED.00148 — Gene Therapy for Metachromatic Leukodystrophy:
- Outlines the Medically Necessary and Not Medically Necessary criteria for gene therapy for metachromatic leukodystrophy
- RAD.00069 — Absolute Quantitation of Myocardial Blood Flow Measurement:
- The use of absolute quantitation of myocardial blood flow testing is considered Investigational & Not Medically Necessary for all indications
- SURG.00011 — Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting:
- Revised ocular indications, including the addition of SurSight to Medically Necessary and Not Medically Necessary section and added new Medically Necessary criterion addressing non-healing or persistent corneal epithelial defects
- Removed VersaWrap from Investigational & Not Medically Necessary statement
- Removed Phasix Mesh from Investigational & Not Medically Necessary statement
- Added Phasix Mesh and Phasix ST Mesh to Medically Necessary and Not Medically Necessary statements
- CG-DME-54 — Mechanical Insufflation-Exsufflation Devices:
- Outlines the Medically Necessary and Not Medically Necessary criteria for use of mechanical insufflation-exsufflation devices
Medical PoliciesOn May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to HealthKeepers, Inc. These medical policies take effect October 26, 2024. Publish Date | Medical Policy Number | Medical Policy Title | New or Revised | 6/28/2024 | ANC.00009 | Cosmetic and Reconstructive Services of the Trunk, Groin, and Extremities | Revised | 6/28/2024 | *MED.00055 | Wearable Cardioverter Defibrillators | Revised | 5/16/2024 | *MED.00148 | Gene Therapy for Metachromatic Leukodystrophy | Revised | 6/28/2024 | *RAD.00069 | Absolute Quantitation of Myocardial Blood Flow Measurement | New | 6/28/2024 | *SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Revised | 6/28/2024 | SURG.00121 | Transcatheter Heart Valve Procedures | Revised |
Clinical UM GuidelinesOn May 9, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to HealthKeepers, Inc. These guidelines were adopted by the medical operations committee for Anthem HealthKeepers Plus members on June 27, 2024. These guidelines take October 26, 2024. Publish Date | Clinical UM Guideline Number | Clinical UM Guideline Title | New or Revised | 6/28/2024 | *CG-DME-54 | Mechanical Insufflation-Exsufflation Devices | New | 6/28/2024 | CG-DME-55 | Automated External Defibrillators for Home Use | New | 6/28/2024 | CG-MED-68 | Therapeutic Apheresis | Revised | 6/28/2024 | CG-MED-97 | Biofeedback and Neurofeedback | New |
HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-068661-24-CPN68109 Prior Authorization | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 10, 2024 Prior authorization requirement changesEffective December 1, 2024 Effective December 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by HealthKeepers, Inc. for Anthem HealthKeepers Plus members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0141U | Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected | 0142U | Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected | 0321U | Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique | 0449T | Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; initial device | 21086 | Impression & Custom Preparation; Auricular Prosthesis | 36468 | Injection(s) of sclerosant for spider veins (telangiectasia), limb or trunk | 36473 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated | 37241 | Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; venous, other than hemorrhage (for example, congenital or acquired venous malformations, venous and capillary hemangiomas, varices, varicoceles) | 61885 | Subq Placement Cranial Neurostimulator Pulse Generator/Receiver; W/Connection Sngle Electrod Array | 64568 | Open implantation of cranial nerve (for example, vagus nerve) neurostimulator electrode array and pulse generator | 64569 | Revision or replacement of cranial nerve (for example, vagus nerve) neurostimulator electrode array, including connection to existing pulse generator | 66183 | Insertion of anterior segment aqueous drainage device, without extraocular reservoir, external approach | 66989 | Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (for example, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (for example, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; with insertion of intraocular (for example, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more | 66991 | Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (for example, irrigation and aspiration or phacoemulsification); with insertion of intraocular (for example, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more | 82107 | Alpha-fetoprotein (AFP); AFP-L3 fraction isoform and total AFP (including ratio) | 86304 | Immunoassay, Tumor Antigen, Quantitative; Ca 125 | 95976 | Electronic analysis of implanted neurostimulator pulse generator/transmitter (for example, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with simple cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional | 95977 | Electronic analysis of implanted neurostimulator pulse generator/transmitter (for example, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with complex cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional | 97760 | Orthotic(s) management and training (including assessment and fitting when not otherwise reported), upper extremity(ies), lower extremity(ies) and/or trunk, initial orthotic(s) encounter, each 15 minutes | 97763 | Orthotic(s)/prosthetic(s) management and/or training, upper extremity(ies), lower extremity(ies), and/or trunk, subsequent orthotic(s)/prosthetic(s) encounter, each 15 minutes | A2026 | Restrata MiniMatrix, 5 mg | A4438 | Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each | C1734 | Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable) | C9796 | Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (for example, porcine small intestine submucosa [SIS]) | C9797 | Vascular embolization or occlusion procedure with use of a pressure-generating catheter (for example, one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction | E0735 | Non-invasive vagus nerve stimulator | E2298 | Complex rehabilitative power wheelchair accessory, power seat elevation system, any type | Q4305 | American Amnion AC Tri-Layer, per sq cm | Q4306 | American Amnion AC, per sq cm | Q4307 | American Amnion, per sq cm | Q4308 | Sanopellis, per sq cm | Q4309 | VIA Matrix, per sq cm | Q4310 | Procenta, per 100 mg |
To request PA, you may use one of the following methods: - Web: Log in to Availity.com.
- Fax: 800-964-3627
- Phone: 800-901-0020
Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://providers.anthem.com/va on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at 800-901-0020 for assistance with PA requirements. UM AROW #: A2024M187 HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-065608-24-CPN65118 Effective February 1, 2025 Effective February 1, 2025, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non‑compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 0456U | Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS), gene expression testing of 19 genes, whole blood, with analysis of anti-cyclic citrullinated peptides (CCP) levels, combined with sex, patient global assessment, and body mass index (BMI), algorithm reported as a score that predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy PrismRA®, Scipher Medicine®, Scipher Medicine® | 0459U | β-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology Elecsys® Total Tau CSF (tTau) and β-Amyloid (1-42) CSF II (Abeta 42) Ratio, Roche Diagnostics Operations, Inc (US owner/operator) | 0468U | Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis NASHnext™ (NIS4™), Labcorp, Labcorp | J0687 | Injection, cefazolin sodium (WG Critical Care), not therapeutically equivalent to J0690, 500 mg | J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | J2183 | Injection, meropenem (WG Critical Care), not therapeutically equivalent to J2185, 100 mg | J2184 | Injection, meropenem (B. Braun), not therapeutically equivalent to J2185, 100 mg | J2281 | Injection, moxifloxacin (Fresenius Kabi), not therapeutically equivalent to J2280, 100 mg |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at the number on the back of the patient’s member ID card for assistance with PA requirements. UM AROW #: A2024M2186 Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-068215-24-CPN67511 The following services will be added to precertification for the effective dates listed below. Precertification responsibilityThe ordering or rendering provider of service is responsible for completing the prior authorization process. HMO plansServices that require precertification will be denied if rendered without the appropriate prior authorization for in-network providers. HMO members may not have benefits for non-emergency services rendered outside of the network and are subject to review and may be denied. PPO plansPrecertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. EPO plansPrecertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. To request precertificationAccess Availity.com. For maternity, medical, surgical precertification, call the number listed on the back of the member’s ID card. For mental health and substance use precertification, call 800-755-0851. Professionals are available 24 hours a day, seven days a week. Add to precertificationCriteria | Criteria description | Code | Effective date | LAB.00042 | Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy | 0456U | February 1, 2025 | LAB.00046 | Testing for Biochemical Markers for Alzheimer’s Disease | 0459U | February 1, 2025 | LAB.00019 | Proprietary Algorithms for Liver Fibrosis | 0468U | February 1, 2025 | TRANS.00039 | Portable Normothermic Organ Perfusion Systems | 0894T | February 1, 2025 | TRANS.00039 | Portable Normothermic Organ Perfusion Systems | 0895T | February 1, 2025 | TRANS.00039 | Portable Normothermic Organ Perfusion Systems | 0896T | February 1, 2025 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J0687 | February 1, 2025 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J0688 | February 1, 2025 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J0689 | February 1, 2025 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J0744 | February 1, 2025 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J2183 | February 1, 2025 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J2184 | February 1, 2025 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | J2281 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4311 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4312 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4313 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4314 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4315 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4316 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4317 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4318 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4319 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4320 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4321 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4322 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4323 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4324 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4325 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4326 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4327 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4328 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4329 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4330 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4331 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4332 | February 1, 2025 | SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4333 | February 1, 2025 |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CM-067493-24
The following services will be added to precertification for the effective dates listed below.
|
Precertification responsibility
The ordering or rendering provider of service is responsible for completing the prior authorization process.
HMO plans: Services that require precertification will be denied if rendered without the appropriate prior authorization for in-network providers. HMO members may not have benefits for non-emergency services rendered outside of the network and are subject to review and may be denied.
PPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement.
EPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. No out-of-network benefit is available with the exception of ER/urgent care and authorized services.
|
To request precertification with the Virginia plan
Access Availity at Availity.com.
For maternity, medical, or surgical precertification, call the number listed on the back of the member’s ID card. For mental health and substance use precertification, call 800-755-0851. Professionals are available 24 hours a day, seven days a week.
|
Add to precertification
|
Criteria |
Criteria description |
Code |
Effective date |
MED.00140
|
Gene Therapy for Beta Thalassemia
|
J3393
|
2/1/2025
|
MED.00146
|
Gene Therapy for Sickle Cell Disease
|
J3394
|
2/1/2025
|
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CM-068530-24 At a glance: - High Performing Providers will also be known as Anthem Diamond Providers.
- Providers receiving a designation based on the Blue National Physician Performance Dataset will also be known as Anthem Diamond Providers (National).
High Performing Provider programOver the last several months, we have communicated with our providers about our High Performing Provider program. PCPs and specialists meeting certain criteria are designated High Performing Providers. High Performing Providers may also be referred to as Anthem Diamond Providers. As a reminder, the following specialties may be designated High Performing Providers (aka Anthem Diamond Providers) from this program: - PCP: family practice, general practice, geriatric medicine, internal medicine, pediatric medicine, and nurse practitioners
- Specialists: cardiology, endocrinology, nephrology, neurology, neurosurgery, obstetrics gynecology, orthopedic surgery, psychiatry, pulmonology, and rheumatology
If you have any questions about this program, contact Provider Services or your local provider relationship management representative. Blue National Physician Performance DatasetThis is an Anthem designation program for providers in networks supporting Anthem national accounts and certain out-of-area providers. As we previously communicated to you, effective January 1, 2025, Anthem may incorporate insights from the Blue National Physician Performance Dataset (Dataset) in various initiatives. For Anthem national accounts and certain out-of-area providers, Anthem will use data made available in the Dataset to assess individual physician’s performance at the NPI level. The individual physician’s performance is assessed across the three domains — cost of care/efficiency, quality of care, and appropriateness of care — for the following 16 primary care and specialty areas: cardiothoracic surgery, cardiovascular disease, endocrinology, neurology, ob/gyn, ophthalmology, orthopedics, pediatrics, primary care, pulmonology, surgery, urology, gastroenterology, otolaryngology, oncology, and radiation oncology. The providers who qualify for the designation from this Dataset program will also be referred to as Anthem Diamond Providers (National). If you have any questions regarding this, contact your local provider relationship management representative. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-070326-24 Our digital-first initiative allows you to submit EDI-corrected claims using the Availity Essentials website or through electronic data interchange (EDI). The corrected claims process begins when a claim has already been adjudicated. Multiple types of errors that occur can typically be corrected quickly with the options below. Availity Essentials corrected claim submissionIf we have already accepted the original claim for processing, you can recreate it and submit it as a corrected replacement or cancellation (void) of the original claim. Follow these steps:- In the Availity Essentials menu, select Claims & Payments and then select Professional Claim or Facility Claim, depending on which type of claim you want to correct:
- Enter the claim information, and set the billing frequency and payer control number as follows:
- Replacement of Prior Claim or Void/Cancel of Prior Claim
- Billing Frequency (or Frequency Type) field in the Claim Information section (for professional and facility claims) or Ancillary Claim/Treatment Information section (for dental claims)
- Ensure all lines are submitted on the claim
- Note: The original claim processed will be voided, and the new corrected and/or replacement claim will be processed.
- Set the Payer Control Number (ICN / DCN) (or Payer Claim Control Number) field to the claim number we assigned to the claim. You can obtain this number from the 835 ERA or Remittance Inquiry on Payer Spaces.
- Submit the claim.
EDI corrected claim submissionCorrected claims submitted electronically must also have the applicable frequency code. The frequency code indicates the claim is a correction of a previously submitted and adjudicated claim. Providers should use one of the following: - For corrected professional (837P) claims, use one of the following frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
- 6 — Corrected Claim of Prior Claim
- 7 — Replacement of Prior Claim
- 8 — Void/Cancel Prior Claim
Note: When a replacement or corrected claim (0XX7 or 0XX6) is submitted, the original claim will be voided, and the new or corrected claim will be processed: - For corrected institutional (837I) claims, use bill type frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
- 0XX6 — Corrected Claim of Prior Claim
- 0XX7 — Replacement of Prior Claim
- 0XX8 — Void/Cancel Prior Claim
Please check with your practice management software vendor, billing service, or clearinghouse for the full details of submitting corrected claims. We encourage you and your staff to use the digital methods available to submit corrected claims to save costs in mailing, paper, and your valuable time. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-068980-24 This article was updated on October 9, 2024, to remove Ilumya as non-preferred from the step therapy requirements section below. Ilumya is not being added to the step therapy program at this time. Specialty pharmacy updates for Anthem are listed below. Anthem’s medical specialty drug review team manages prior authorization (PA) clinical review of non-oncology use of specialty pharmacy drugs. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request PA review for your patients’ continued use of these medications. Inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code. Prior authorization updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our PA review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® Code(s) | CC-0003* | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0062 | Simlandi (adalimumab-ryvk) | J3590 | CC-0261 | Winrevair (sotatercept-csrk) | C9399, J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Note: PA requests for certain medications may require additional documentation to determine medical necessity. Step therapy updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. Access our Clinical Criteria to view the complete information for these step therapy updates. Clinical Criteria | Status | Drug | HCPCS or CPT Code(s) | CC-0003 | Non-preferred | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0062 | Non-preferred | Cimzia (certolizumab pegol) | J0717 | CC-0042 | Non-preferred | Cosentyx intravenous (secukinumab) | C9399, J3490, J3590, C9166 | CC-0050 | Non-preferred | Omvoh (mirkizumab-mrkz) | C9168, J3590 |
Quantity limit updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT Code(s) | CC-0062 | Simlandi (adalimumab-ryvk) | J3590 | CC-0261 | Winrevair (sotatercept-csrk) | C9399, J3590 |
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CM-061663-24-CPN60563, MULTI-BCBS-CM-069897-24 Specialty pharmacy updates for Anthem are listed below. Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. For Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. prior authorization, clinical review of these specialty pharmacy drugs will be managed by Anthem. Drugs used for the treatment of oncology will still require pre-service clinical review by Carelon Medical Benefits Management, Inc., a separate company. This would apply to members with Preferred Provider Organization (PPO), Healthkeepers (HMO), and POS AdvantageOne, Act Wise (CDH plans). Note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Inclusion of the national drug code (NDC) on your claim will help expedite claim processing of drugs billed with a not otherwise classified (NOC) code. The health plan requires that claims for injection services performed in the office setting must include the applicable HCPCS J-code, Q-code, or S-code, with the corresponding national drug code (NDC) for the injected substance. This requirement is consistent with CMS guidelines. A covered drug will not be eligible for reimbursement when the NDC is not reported on the same claim. Prior authorization updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0027* | Jubbonti; Wyost (denosumab-bbdz) | Q5136 | CC-0002* | Nypozi (filgrastim-txid) | C9399, J3590 | CC-0266* | Rytelo (imetelstat) | C9399, J9999 | CC-0003* | Yimmugo (immune globulin intravenous, human–dira) | J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Step therapy updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. The current Orencia step therapy preferred product list under the medical benefit is being modified to include only those that are considered medical benefit drugs. Access our Clinical Criteria to view the complete information for these step therapy updates. Clinical Criteria | Status | Drug | HCPCS or CPT code(s) | CC-0002 | Non-preferred | Nypozi | C9399, J3590 | CC-0003 | Non-preferred | Yimmugo | J3590 |
Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Site of care updatesEffective for dates of service on and after February 1, 2025, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our site of care review process. Access our Clinical Criteria to view the complete information for these site of care updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0003 | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0066 | Tyenne (tocilizumab-aazg) | Q5135 |
Quantity limit updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0266 | Rytelo (imetelstat) | C9399, J9999 | CC-0027 | Jubbonti; Wyost (denosumab-bbdz) | Q5136 |
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069728-24-CPN69536 Effective for dates of service on and after February 1, 2025, the following Clinical Criteria were developed and might result in services that were previously covered but may now be found to be not medically necessary. Anthem Blue Cross and Blue Shield and its affiliate HealthKeepers, Inc. will manage prior authorization for these specialty pharmacy drugs. Drugs used for the treatment of oncology will still require prior authorization by Carelon Medical Benefits Management, Inc., a separate company. This applies to members with a PPO and an HMO. Access the Clinical Criteria document information for details. CC-0028 | Benlysta (belimumab) | CC-0034 | Hereditary Angioedema Agents | CC-0096 | Asparagine Specific Enzymes | CC-0156 | Reblozyl (luspatercept) |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CM-069584-24 Enhanced adherence mitigates healthcare costs and improves patient outcomes and quality of life. Promoting medication adherence and advocating for statin use among diabetes patients is critical. Statin use in diabetes:- Diabetics are two to four times more likely to die from heart disease (American Heart Association).
- Statins lower LDL cholesterol, reducing cardiovascular events by 25 to 60%.
- Statin use is low, particularly in younger, female, and black individuals.
- Delayed statin use increases cardiovascular disease risk in diabetic patients.
- National guidelines recommend statin therapy for diabetics ages 40 to 75, regardless of LDL levels.
- CMS has adopted the Statin Use in Persons with Diabetes (SUPD) measure to combat cardiovascular death in diabetic patients.
Medication adherence:- Poor adherence increases morbidity and mortality, causing more than 125,000 deaths and 10% of hospitalizations annually in the United States.
- Forty-five percent of U.S. adults have hypertension and only 24% manage it effectively, largely due to non-adherence.
- High adherence in diabetic patients reduces hospitalization risks by 30%.
- Improved adherence can save $1,200 to $8,000 per patient annually.
Supporting patients:- Simplify the regimen: Prescribe medications with fewer daily doses.
- Regular follow-ups: Ensure correct medication use and adjust doses as needed.
- Clear communication: Explain medication benefits, risks of non-compliance, and side effects.
- Extended prescriptions: Provide 90 to 100 days’ supply and sufficient refills.
- Home delivery: Eliminate transportation barriers.
- Address statin hesitancy: Discuss pros and cons and involve family in decisions.
- Use technology: Set up reminders through mobile apps, SMS, email, or pill containers.
- Address cost issues: Prescribe affordable options and explore assistance programs.
- Personalized care: Tailor medication plans to the patient's lifestyle and needs.
References: - American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S179–S218
- Bradley CK, Wang TY, Li S, et al. Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 2019;8(7). doi: https://doi.org/10.1161/jaha.118.011765
- Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016. MMWR Morb Mortal Wkly Rep 2018;67:983–991. doi: http://dx.doi.org/10.15585/mmwr.mm6735a4
- 2 Tarn DM, Barrientos M, Pletcher MJ, et al. Perceptions of Patients with Primary Nonadherence to Statin Medications. The Journal of the American Board of Family Medicine. 2021;34(1):123-131. doi: https://doi.org/10.3122/jabfm.2021.01.200262
- CDC. Statins and Diabetes: What You Should Know. Centers for Disease Control and Prevention. Published January 30, 2023. https://www.cdc.gov/diabetes/library/features/Statins_Diabetes.html
- Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117–125
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11). doi: https://doi.org/10.1161/cir.0000000000000678
- Collins R, Reith C, Emberson J, et al. The Lancet. 2016;388(10059):2532-2561Interpretation of the evidence for the efficacy and safety of statin therapy. doi: https://doi.org/10.1016/S0140-6736(16)31357-5
- Hla D, Jones R, Blumenthal RS, et al. Assessing severity of statin side effects: Fact vs fiction. American College of Cardiology. April 09, 2018. Accessed May 17, 2023. https://www.acc.org/latest-in-cardiology/articles/2018/04/09/13/25/assessing-severity-of-statin-side-effects
- Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E, McShea K. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease. Annals of Internal Medicine. 2020;173(10):806-812. doi: https://doi.org/10.7326/m20-4680
- Brown M, Sinsky CA. Medication Adherence. Improve Patient Outcomes and Reduce Costs. American Medical Association Steps Forward. 5 June 2015. https://edhub.ama-assn.org/steps-forward/module/2702595. Accessed 16 May 2023
- Eight reasons patients don’t take their medications. American Medication Association. Feb 22, 2023. Accessed May 17, 2023. https://www.ama-assn.org/delivering-care/patient-support-advocacy/8-reasons-patients-dont-take-their-medications
- El Halabi J, Minteer W, Boehmer KR. Identifying and Managing Treatment Nonadherence. Medical Clinics of North America. 2022;106(4):615-626. doi: https://doi.org/10.1016/j.mcna.2022.02.003
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-069868-24-CPN69806 Quality Management | Anthem Blue Cross and Blue Shield | Commercial / Anthem Blue Cross and Blue Shield | Medicare Advantage / HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 25, 2024 Time to prepare for HEDIS medical record reviewAt a glance:- Care providers must prepare for HEDIS® medical record reviews starting January 2025.
- Care providers will submit records through Remote Electronic Medical Record (EMR) Access Service, website upload, fax, secure file transfer protocol (SFTP), mail, or on-site.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). BackgroundEach year, we perform a review of a sample of our members’ medical records as part of the HEDIS quality study. HEDIS is part of a nationally recognized quality improvement initiative and is used by the Centers for Medicare & Medicaid Services (CMS), the National Committee for Quality Assurance (NCQA), and several states to monitor the performance of managed care organizations. We will begin requesting medical records in January 2025. No special authorization is needed for you to share member medical record information with us since quality assessment and improvement activities are routine parts of healthcare operations. Ways to submit your records in our preferred order:- Remote EMR Access Service: We offer the Remote EMR Access Service to care providers to submit member medical record information to us. If you are interested in more information, contact us at Centralized_EMR_Team@anthem.com.
- Upload: Medical records can be uploaded to our secure website using the instructions in the request document.
- Fax: Medical records can be faxed to us using the instructions in the request document.
- SFTP: Medical records can be uploaded via a secure website.
- U. S. Postal Service: Medical records can be mailed to us using the instructions in the request document.
- On-site: Medical records can be pulled by a representative at your local office where medical records are located.
HEDIS review is time sensitive, so submit the requested medical records within the timeframe indicated in the initial HEDIS request document. We appreciate the care you provide our members. Your assistance is crucial to ensuring our data is statistically valid, auditable, and accurately reflects quality performance. Contact usAvaility Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to https://Availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat. For additional support, visit the Contact Us section of our provider website for the appropriate contact. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CDCRCM-069953-24-CPN69632, VABCBS-CDCRCM-071185-24-CPN71157 Quality Management | HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products | October 24, 2024 Provider: CAHPS awarenessThe Consumer Assessment of Healthcare Providers and Systems® (CAHPS) is an annual standardized survey conducted anonymously by a third-party vendor (Center for the Study of Services) to assess a random sample of consumers' experiences with their health plan, their personal provider, and healthcare services. Refer to attachment to view full details. CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc. VABCBS-CD-068382-24-CPN67980 ATTACHMENTS (available on web): Provider: CAHPS awareness (pdf - 0.09mb) |